Research study Program year 2025 Source: CMS Open Payments

103 CRADA various titles

Research payments

$176,777,827

13 payments

Through program year 2025, $176,777,827 in research payments was reported against 103 CRADA various titles, across 13 payments, paid by Amgen Inc..

Paid by: Amgen Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$32,401,347	2
2024	Research	$221,996	2
2023	Research	$56,594	1
2022	Research	$21,298,847	1
2021	Research	$54,604,712	2
2020	Research	$47,283,619	3
2019	Research	$20,910,713	2

Breakdown

Who paid Research payments · program years 2019–2025

Amgen Inc. $176,777,827 13 payments

Who received the money Research payments · program years 2019–2025

Nci Clinical Repository Organisation paid for research $176,021,427 8 payments
National Cancer Institute Organisation paid for research $750,000 3 payments
Capital Technology Information Svcsdba Ctis INC Organisation paid for research $6,400 2 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

1 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

James Doroshow Bethesda, MD Named on 13 payments

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.